Clinical Trial 51716

Chesterfield, MO 63005


12 visits over 1.5 years.

Study is to test the safety and efficacy of Semaglutide and the fixed-dose combination of Cilofexor and Firsocostat, alone and in combination, in subjects with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH).

Qualified Participants Must:

• Be between 18-80 years old
• Have a BMI of 23 or more
• Have no other liver disorders

Qualified Participants May Receive:

Up to $1450 if all visits and procedures are completed

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.